These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11600753)

  • 1. Anti-thymocyte globulin in scleroderma.
    Denman AM
    Rheumatology (Oxford); 2001 Oct; 40(10):1192. PubMed ID: 11600753
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of antithymocyte globulin in severe cases of progressive systemic sclerosis.
    Tarkowski A; Lindgren I
    Transplant Proc; 1994 Dec; 26(6):3197-9. PubMed ID: 7998113
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of systemic sclerosis with antithymocyte globulin.
    Balaban EP; Zashin SJ; Geppert TD; Lipsky PE; Condie RM
    Arthritis Rheum; 1991 Feb; 34(2):244-5. PubMed ID: 1994926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of serum from patients with systemic scleroderma on collagen biosynthesis in the fibroblasts before and after administration of antilymphocyte globulin].
    Panasiuk AF; Lebedev DA; Gandzha IM; Iashchenko OB
    Ter Arkh; 1983; 55(2):113-5. PubMed ID: 6845188
    [No Abstract]   [Full Text] [Related]  

  • 5. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.
    Stratton RJ; Wilson H; Black CM
    Rheumatology (Oxford); 2001 Jan; 40(1):84-8. PubMed ID: 11157146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxins in progressive systemic sclerosis.
    Pruzanski W
    Clin Exp Rheumatol; 1983; 1(3):280-1. PubMed ID: 6681144
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2005 Sep; 24(9):1320-6. PubMed ID: 16143251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical uses of anti-thymocyte globulin (ATGAM), Part I.
    Gilbert C
    N C Med J; 1984 Nov; 45(11):737-9. PubMed ID: 6392893
    [No Abstract]   [Full Text] [Related]  

  • 9. Scleroderma treated with immunosuppressive drugs.
    Kurwa AR; Denman AM
    Br J Dermatol; 1979 Jul; 101 Suppl 17():56-7. PubMed ID: 313805
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical uses of anti-thymocyte globulin (ATGAM), Part II.
    Gilbert C
    N C Med J; 1984 Dec; 45(12):773-5. PubMed ID: 6392895
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful bone marrow transplantation with rabbit anti-human thymocyte globulin in aplastic anemia. Report of a case previously treated with equine anti-human lymphocyte globulin.
    Yoshida Y; Ichinoe T; Dodo M; Noukawa M; Maeda A; Oguma S; Tajima M; Yamamoto K; Okuma M
    Int J Hematol; 1994 Jul; 60(1):79-83. PubMed ID: 7919240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with anti-thymocyte globulin in severe aplastic anemia].
    González N; Arranz R; Fernández-Garese D; Lozano M; Vázquez L; Fernández-Rañada JM
    Sangre (Barc); 1986; 31(1):17-22. PubMed ID: 3704881
    [No Abstract]   [Full Text] [Related]  

  • 13. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I; Hsaiky L; Brown K; Abouljoud M
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.
    Ansari D; Höglund P; Andersson B; Nilsson J
    J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Jurkat cell-reactive anti-T lymphocyte globulin and fetal anti-thymocyte globulin preparations in the treatment of aplastic anemia.
    Serefhanoglu S; Buyukasik Y; Purnak T; Goker H; Sayinalp N; Haznedaroglu IC; Ozcebe OI
    Med Princ Pract; 2011; 20(4):341-4. PubMed ID: 21576994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-thymocyte globulin therapy of hematologic disorders.
    Magno J; Kaneshiro M; Doney K; Nakamura J
    Hawaii Med J; 1987 Mar; 46(3):85-91. PubMed ID: 3108196
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation.
    Mandelbrot D
    J Am Soc Nephrol; 2009 Jun; 20(6):1170-1. PubMed ID: 19470672
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status of GVHD prophylaxis using anti-thymocyte globulin in Japan].
    Fuji S; Fukuda T
    Rinsho Ketsueki; 2013 Jul; 54(7):649-52. PubMed ID: 23912348
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-thymocyte globulin therapy in a patient with pANCA vasculitis and crescentic glomerulonephritis.
    Lukas R; Keller F
    Nephron; 1998; 78(2):231. PubMed ID: 9496748
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-thymocyte globulin for immunosuppression].
    Collste LG; Franksson C; Groth CG; Jacobson S; Magnusson G; Schantz B; Svehag SE; Werner B
    Nord Med; 1971; 86(46):1358. PubMed ID: 4944024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.